News

Pharmabiz18h
Ambry Genetics’ CARE programme validated for accuracy in identifying patients for hereditary cancer testing
Ambry Genetics’ CARE programme validated for accuracy in identifying patients for hereditary cancer testing: Aliso Viejo, California Saturday, June 28, 2025, 18:00 Hrs [IST] Amb ...
Pharmabiz19h
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research
Applied StemCell releases hiEX Research iPSC Exosomes to explore next-generation regenerative medicine research: Milpitas, California Saturday, June 28, 2025, 17:00 Hrs [IST] Appl ...
Pharmabiz20h
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom
Icon Group and Varian expand partnership to deliver advanced cancer technology across the United Kingdom: London Saturday, June 28, 2025, 16:00 Hrs [IST] Icon Group, a global lead ...
Pharmabiz21h
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis
Biodexa Pharma activates first clinical study site for phase 3 Serenta trial in familial adenomatous polyposis: United Kingdom Saturday, June 28, 2025, 15:00 Hrs [IST] Biodexa Pha ...
Pharmabiz22h
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada
KalVista Pharma inks licensing agreement with Pendopharm to commercialize sebetralstat for HAE in Canada: Cambridge, Massachusetts Saturday, June 28, 2025, 14:00 Hrs [IST] KalVist ...
Pharmabiz23h
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma
US FDA approves label updates for Bristol Myers’ CAR T cell therapies, Breyanzi for LBCL & lymphomas and Abecma for multiple myeloma: Princeton, New Jersey Saturday, June 28, 20 ...